Eupraxia Pharmaceuticals (EPRX) Other Non Operating Income (2023 - 2026)
Eupraxia Pharmaceuticals' Other Non Operating Income came in at $2.25 million for the quarter ended Jun 30, 2026, compared with -$733,961 a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Other Non Operating Income (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eupraxia Pharmaceuticals reported Other Non Operating Income of $1.56 million; for the year ended Dec 31, 2025, it was -$1.56 million.
- Going back by year, Other Non Operating Income was -$159,214 in the year ended Dec 31, 2024, $66,291 in the year ended Dec 31, 2023 (-72.4%) and $240,547 in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Other Non Operating Income in data going back to the quarter ended Mar 31, 2023.
- Business Quant data shows EPRX's Other Non Operating Income at $2.24 million (quarter ended Mar 31, 2026), -$2.43 million (quarter ended Dec 31, 2025) and -$508,633 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Eupraxia Pharmaceuticals | 312.86 Mn | 311.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Sep 30, 2025 | -508,633.00 |
| Jun 30, 2025 | -733,961.00 |
| Mar 31, 2025 | 51,362.00 |
| Dec 31, 2024 | -71,047.00 |
| Sep 30, 2024 | 124,431.00 |
| Jun 30, 2024 | -75,041.00 |
| Mar 31, 2024 | 144,913.00 |
| Dec 31, 2023 | 59,281.00 |
| Sep 30, 2023 | -25,965.00 |
| Jun 30, 2023 | 9,942.00 |
| Mar 31, 2023 | 23,033.00 |
API Access
Eupraxia Pharmaceuticals Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();